Detail akcie PharmaRoth Labs online

Business Summary: PharmaRoth Labs, Inc. is a nutraceutical company. The Company is focused on diabetes prevention and treatments. The Company is engaged in marketing and selling nutraceutical drugs. The Company is engaged in the production, marketing and distribution of Sucanon, which is a clinically tested herbal-based nutraceutical treatment for Type-II diabetes. Sucanon is a member of a class of diabetic medications called insulin sensitizers. Sucanon helps the body to use its own insulin. Sucanon transports sugar out of the blood stream and into cells where it can be burned. Sucanon helps muscle cells use insulin and thus draw sugar out of the blood stream. Clinical studies have shown that Sucanon reduces blood sugar readings by 25% to 30% and brings high blood sugar into normal range. Clinical studies have shown that Sucanon reduces fatigue. Clinical studies have also shown that Sucanon reduces excess thirst and excess urination.
Financial Summary: BRIEF: For the nine months ended 31 March 2011, PharmaRoth Labs Inc revenues increased from $0K to $200K. Net loss increased from $15K to $383K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Professional fees increase from $0K to $210K (expense), Interest expense increase from $0K to $8K (expense).